Compare MNSO & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNSO | XENE |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 2020 | 2014 |
| Metric | MNSO | XENE |
|---|---|---|
| Price | $10.22 | $36.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 19 |
| Target Price | $14.17 | ★ $72.43 |
| AVG Volume (30 Days) | 1.2M | ★ 1.8M |
| Earning Date | 11-20-2026 | 11-02-2026 |
| Dividend Yield | ★ 6.75% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $311,000.00 |
| Revenue This Year | $15.49 | N/A |
| Revenue Next Year | $12.98 | $2,045.70 |
| P/E Ratio | $20.04 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.55 | $33.38 |
| 52 Week High | $22.82 | $72.66 |
| Indicator | MNSO | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 58.56 | 35.58 |
| Support Level | $8.61 | N/A |
| Resistance Level | $10.64 | $39.92 |
| Average True Range (ATR) | 0.24 | 1.23 |
| MACD | 0.12 | 0.91 |
| Stochastic Oscillator | 78.03 | 59.44 |
MINISO Group Holding Ltd is a value retailer offering a variety of trendy lifestyle products featuring IP design. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand -Chinese Mainland and MINISO brand-Overseas which is engaged in the Design, buying, and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying, and sale of pop toys. The company generates maximum revenue from theMINISO brand -Chinese Mainland segment. Geographically, it derives a majority of its revenue from Chinese Mainland.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.